Find out how to get involved in developing Medicaid health homes, one of the ways states can get funding from the Affordable Care Act to provide coordinated, patient-centered care.
Explores how wellness programs can encourage people to adopt healthy behaviors, provides examples of model programs, and includes a checklist for designing consumer-friendly wellness programs.
If you have reliable health insurance, you may not think of sports arenas as typical health care venues. But for the millions of uninsured and underinsured Americans, free health clinics, such as the one held last week by Care Harbor LA at L.A. Sports Arena, are often the only option. Thousands of L.A.-area residents waited in line overnight last Monday to receive one of the 4,800 wristbands for Care Harbor’s 5th annual free health care clinic, held Thursday to Sunday.
This series explains what Accountable Care Organizations (ACOs) are and discusses how to build ACOs that meet patient needs, improve quality, and reduce health care costs.
Lays out the basics of how managed long-term care in Medicaid works; highlights key questions for advocates to ask when evaluating how managed care will affect consumers.
Have you ever gone to the doctor and had to repeat a test because they didn't have the results on hand? Do you ever feel that your doctors don't talk to each other? Or that no one doctor knows all of the medications you're taking and why? These kinds of things happen frequently. And they not only lead to higher costs: They can also be dangerous.
Not a week goes by without another report reminding us that the United States spends more on health care than any other country in the world, yet has worse health outcomes than most. How do we solve this problem and get more for our money? We need to focus on getting each person the right care at the right time.
Is newer always better? Not in the case of a pricey new cancer drug, according to clinical trial data and experts around the nation. The drug, Zaltrap, is getting lots of media attention not because it is novel for a new drug to be twice as expensive as its competitor and no more effective (the FDA doesn't require new medicines to be either more effective or less costly than existing drugs), but because Memorial Sloan-Kettering Cancer Center—one of the nation's premier cancer treatment centers—has decided that it won't offer Zaltrap to its patients.
When Avandia entered the market, it was touted as one of the best medicines available to help people with type 2 diabetes. The great potential of this new diabetes wonder drug was proclaimed in an article in the prestigious New England Journal of Medicine, and Avandia was quickly adopted as the standard of care. Sadly, an important piece of information came out much later. Avandia has an unfortunate and dangerous side effect: It increases the risk of heart attack. A lot.